Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

van Vollenhoven, R., Askanase, A. D., Bomback, A. S., Bruce, I. N., Carroll, A., Dall’Era, M., Daniels, M., Levy, R. A., Schwarting, A., Quasny, H. A., Urowitz, M. B., Zhao, M.-H., & Furie, R. (2022). Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Science & Medicine, 9(1), e000634. https://doi.org/10.1136/lupus-2021-000634
Authors:
Ronald van Vollenhoven
Anca D Askanase
Andrew S Bomback
Ian N Bruce
Angela Carroll
Maria Dall'Era
Mark Daniels
Roger A Levy
Andreas Schwarting
Holly A Quasny
Murray B Urowitz
Ming-Hui Zhao
Richard Furie
Affiliated Authors:
Anca D Askanase
Andrew S Bomback
Author Keywords:
lupus erythematosus, systemic
lupus nephritis
outcome assessment, health care
therapeutics
Publication Type:
Article
Unique ID:
10.1136/lupus-2021-000634
PMID:
Publication Date:
Data Source:
PubMed

Record Created: